alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> UT
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED STATEMENT OF INCOME, THE CONSOLIDATED BALANCE SHEET, THE
CONSOLIDATED STATEMENT OF RETAINED EARNINGS AND THE CONSOLIDATED STATEMENT
OF CASH FLOWS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1995
<PERIOD-END>                               DEC-31-1995
<BOOK-VALUE>                                  PER-BOOK
<TOTAL-NET-UTILITY-PLANT>                         1670
<OTHER-PROPERTY-AND-INVEST>                          8
<TOTAL-CURRENT-ASSETS>                             340
<TOTAL-DEFERRED-CHARGES>                             0
<OTHER-ASSETS>                                      69
<TOTAL-ASSETS>                                    2087
<COMMON>                                            76
<CAPITAL-SURPLUS-PAID-IN>                          108
<RETAINED-EARNINGS>                                516
<TOTAL-COMMON-STOCKHOLDERS-EQ>                     700
<PREFERRED-MANDATORY>                                9
<PREFERRED>                                          1
<LONG-TERM-DEBT-NET>                               446
<SHORT-TERM-NOTES>                                   0
<LONG-TERM-NOTES-PAYABLE>                            0
<COMMERCIAL-PAPER-OBLIGATIONS>                     152
<LONG-TERM-DEBT-CURRENT-PORT>                       50
<PREFERRED-STOCK-CURRENT>                            1
<CAPITAL-LEASE-OBLIGATIONS>                          0
<LEASES-CURRENT>                                     0
<OTHER-ITEMS-CAPITAL-AND-LIAB>                     728
<TOT-CAPITALIZATION-AND-LIAB>                     2087
<GROSS-OPERATING-REVENUE>                         1313
<INCOME-TAX-EXPENSE>                                49
<OTHER-OPERATING-EXPENSES>                        1142
<TOTAL-OPERATING-EXPENSES>                        1191
<OPERATING-INCOME-LOSS>                            122
<OTHER-INCOME-NET>                                   2
<INCOME-BEFORE-INTEREST-EXPEN>                     124
<TOTAL-INTEREST-EXPENSE>                            39
<NET-INCOME>                                        85
<PREFERRED-STOCK-DIVIDENDS>                          0
<EARNINGS-AVAILABLE-FOR-COMM>                       85
<COMMON-STOCK-DIVIDENDS>                            71
<TOTAL-INTEREST-ON-BONDS>                           35
<CASH-FLOW-OPERATIONS>                             254
<EPS-PRIMARY>                                        0<F1>
<EPS-DILUTED>                                        0
<FN>
<F1>Northern Illinois Gas is a wholly owned subsidiary of NICOR Inc.
Earning and dividends per share information is therefore omitted.
</FN>
        

</TABLE>
Exhibit 32.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION
1350 In connection with the accompanying Annual Report on Form 10-KSB of
Le@P Technology, Inc. (the Company) for the twelve month period ended December
31, 2007 (the Annual Report), I, Mary E. Thomas, Acting Principal Financial
Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of Sarbanes-Oxley Act of 2002, to my knowledge
and belief that the Annual Report fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the
information contained in the Periodic Report fairly presents, in all material
respects, the financial condition and results of operations of the Company. Date: March
 18, 2008
/s/ Mary E.
 ThomasMary E.
 Thomas
 Acting Principal Financial Officer
Exhibit 31.2


                                 CERTIFICATIONS

I, Michael J. Wolnik, hereby certify that:

(1) I have reviewed this quarterly report on Form 10-QSB of First Ipswich
Bancorp;

(2) Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;

(3) Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
small business issuer as of, and for, the periods presented in this quarterly
report;

(4) The small business issuer's other certifying officer and I are responsible
for establishing and maintaining disclosure controls and procedures (as defined
in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer and
we have:

      a) Designed such disclosure controls and procedures, or caused such
      disclosure controls and procedures to be designed under our supervision,
      to ensure that material information relating to the small business issuer,
      including its consolidated subsidiaries, is made known to us by others
      within those entities, particularly during the period in which this
      quarterly report is being prepared;

      b) Evaluated the effectiveness of the small business issuer's disclosure
      controls and procedures and presented in this quarterly report our
      conclusions about the effectiveness of the disclosure controls and
      procedures, as of the end of the period covered by this quarterly report
      based on such evaluation; and

      c) Disclosed in this quarterly report any change in the small business
      issuer's internal control over financial reporting that occurred during
      the small business issuer's most recent fiscal quarter that has materially
      affected, or is reasonably likely to materially affect, the small business
      issuer's internal control over financial reporting; and

(5) The small business issuer's other certifying officer and I have disclosed,
based on our most recent evaluation of internal control over financial
reporting, to the small business issuer's auditors and the audit committee of
the small business issuer's board of directors (or persons fulfilling the
equivalent functions):

      a) All significant deficiencies and material weaknesses in the design or
      operation of internal control over financial reporting which are
      reasonably likely to adversely affect the small business issuer's ability
      to record, process, summarize and report financial information; and

      b) Any fraud, whether or not material, that involves management or other
      employees who have a significant role in the small business issuer's
      internal controls over financial reporting.


/s/ Michael J. Wolnik
------------------------
Michael J. Wolnik
Chief Financial Officer

November 15, 2004
```

[Federal Register Volume 82, Number 163 (Thursday, August 24, 2017)]
[Notices]
[Page 40173]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-17957]

=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

Notice of Extension of Call for Nominations for the Advisory 
Committee on the Medical Uses of Isotopes

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of extension.

-----------------------------------------------------------------------

SUMMARY: A call for nominations was published by the U.S. Nuclear 
Regulatory Commission (NRC) in the Federal Register on June 22, 2017, 
for the positions of Agreement State representative, nuclear medicine 
physicist, and Health Care Administrator on the Advisory Committee on 
the Medical Uses of Isotopes (ACMUI). The nomination period ended on 
August 21, 2017. This notice confirms a 45-day extension of the 
nomination period until October 5, 2017, for only the Health Care 
Administrator position.

DATES: The nomination period for the notice published June 22, 2017 (82 
FR 28533) is extended. Nominations for the Health Care Administrator 
position are due on or before October 5, 2017.

ADDRESSES: Nomination Process: Submit an electronic copy of a resume or 
curriculum vitae, along with a cover letter, to Ms. Sophie Holiday, 
[email protected]. The resume or curriculum vitae for the Health 
Care Administrator should include the following information, as 
applicable: Education; certification; professional association 
membership and committee membership activities; and number of years, 
recentness, and type of setting for health care administration. The 
cover letter should describe the nominee's current involvement with 
health care administration and express the nominee's interest in the 
position. Nominees for the Health Care Administrator position should 
have professional or personal experience with or knowledge about health 
care administration.

FOR FURTHER INFORMATION CONTACT: Ms. Sophie Holiday, U.S. Nuclear 
Regulatory Commission, Office of Nuclear Material Safety and 
Safeguards; (301) 415-7865; [email protected].

    Dated at Rockville, Maryland, on August 21, 2017.

    For the U.S. Nuclear Regulatory Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2017-17957 Filed 8-23-17; 8:45 am]
 BILLING CODE 7590-01-P
```
Exhibit 21.1



WISCONSIN ELECTRIC POWER COMPANY
SUBSIDIARIES AS OF DECEMBER 31, 2007

The following table includes the subsidiaries of Wisconsin Electric Power Company, an electric, gas and steam utility incorporated in the state of Wisconsin, as well as the percent of ownership, as of December 31, 2007.  Wisconsin Electric is a wholly-owned subsidiary of Wisconsin Energy Corporation.



|Subsidiary (a)             | State of
Incorporationor Organization | PercentOwnership
|-------------------------- | ------------------------------------- | ----------------
|                           |                                       |                 
|Bostco LLC                 | Wisconsin                             | 100%            
|Lake Breeze Wind Farm, LLC | Wisconsin                             | 100%            



|(a) | Omits the names of certain subsidiaries, which if considered in the aggregate as a single subsidiary, would not constitute a "significant subsidiary" as of December 31, 2007.
|--- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
[Federal Register Volume 82, Number 161 (Tuesday, August 22, 2017)]
[Notices]
[Page 39876]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-17659]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel NIAID; Peer Review Meeting.
    Date: September 14, 2017.
    Time: 10:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Tracy A. Shahan, MBA, Ph.D., Scientific Review 
Program, Division of Extramural Activities, National Institutes of 
Health/NIAID, 5601 Fishers Lane, Room #3F31, MSC 79823, Bethesda, MD 
20892-9823, (240) 669-5030, <a href="/cdn-cgi/l/email-protection#0377706b626b626d436d6a626a672d6d6a6b2d646c75"><span class="__cf_email__" data-cfemail="3440475c555c555a745a5d555d501a5a5d5c1a535b42">[email protected]</span></a>.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel NIAID; Peer Review Meeting.
    Date: September 15, 2017.
    Time: 10:00 a.m. to 4:30 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Louis A. Rosenthal, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institutes of Health/NIAID, 5601 Fishers Lane, 
Rm 3G42B, MSC 9834, Bethesda, MD 20892-9834, (240) 669-5070, 
<a href="/cdn-cgi/l/email-protection#61130e12040f1509000d0d00210f080008054f0f08094f060e17"><span class="__cf_email__" data-cfemail="ed9f829e888399858c81818cad83848c8489c3838485c38a829b">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: August 16, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-17659 Filed 8-21-17; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit
99.2  LETTER OF ARTHUR ANDERSEN REPRESENTATION   To the Securities and Exchange Commission  We
received a letter from Arthur Andersen LLP, dated March 29, 2002, representing
that the audit as of and for the year ended December 31, 2001, was subject to
their quality control system for the U.S. accounting and auditing practice to
provide reasonable assurance that the engagement was conducted in compliance
with professional standards, that there was appropriate continuity of Arthur
Andersen personnel working on the audit and availability of national office
consultation, and availability of personnel at foreign affiliates of Arthur
Andersen to conduct the relevant portions of the audit.  Very truly yours,INAMED CORPORATIONBy:
  /s/ PAUL R. KIMMELPaul R. KimmelVice President &
  ControllerMarch 29, 2002
Exhibit 32.2


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In connection with the Quarterly Report of First Ipswich Bancorp (the
"Company") on Form 10-QSB/A for the quarter ended September 30, 2006 as filed
with the Securities and Exchange Commission on the date hereof (the "Report"),
I, Timothy L. Felter, Chief Financial Officer of the Company, certify, pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

      (1)   The Report fully complies with the requirements of Section 13(a) or
            15(d) of the Securities Exchange Act of 1934; and

      (2)   The information contained in the Report fairly presents, in all
            material respects, the financial condition and results of operations
            of the Company.

      This certification is provided solely pursuant to 18 U.S.C. Section 1350
and Item 601(b)(32) of Regulation S-B ("Item 601(b)(32)") promulgated under the
Securities Act of 1933 (the "Securities Act") and the Securities Exchange Act of
1934 (the "Exchange Act"). In accordance with clause (ii) of Item 601(b)(32),
this certification (A) shall not be deemed "filed" for purposes of Section 18 of
the Exchange Act, or otherwise subject to the liability of that section, and (B)
shall not be deemed to be incorporated by reference into any filing under the
Securities Act or the Exchange Act, except to the extent that the Company
specifically incorporates it by reference.


/s/ Timothy L. Felter
-------------------------
Timothy L. Felter
Chief Financial Officer


December 22, 2006
Nicor Gas
Company


Form
10-K


Exhibit
32.02





CERTIFICATION





Pursuant to 18 U.S.C. Section 1350, as
created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned
officer of Nicor Gas Company (the “Company”) hereby
certifies, to such officer’s knowledge, that:





(i)           the
accompanying Annual Report on Form 10-K of the Company for the twelve
month period ended December 31, 2008 (the “Report”) fully
complies with the requirements of Section 13(a) or Section 15(d), as applicable,
of the Securities Exchange Act of 1934, as amended; and





(ii)          the
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.








Dated:  February
      25, 2009
            
            /s/
      RICHARD L. HAWLEYRichard
      L. HawleyExecutive
      Vice President and Chief Financial Officer
[Federal Register Volume 82, Number 158 (Thursday, August 17, 2017)]
[Notices]
[Page 39122]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-17356]


-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. ER17-1840-000]


Canton Mountain Wind, LLC; Supplemental Notice That Initial 
Market-Based Rate Filing Includes Request for Blanket Section 204 
Authorization

    This is a supplemental notice in the above-referenced proceeding of 
Canton Mountain Wind, LLC's application for market-based rate 
authority, with an accompanying rate tariff, noting that such 
application includes a request for blanket authorization, under 18 CFR 
part 34, of future issuances of securities and assumptions of 
liability.
    Any person desiring to intervene or to protest should file with the 
Federal Energy Regulatory Commission, 888 First Street NE., Washington, 
DC 20426, in accordance with Rules 211 and 214 of the Commission's 
Rules of Practice and Procedure (18 CFR 385.211 and 385.214). Anyone 
filing a motion to intervene or protest must serve a copy of that 
document on the Applicant.
    Notice is hereby given that the deadline for filing protests with 
regard to the applicant's request for blanket authorization, under 18 
CFR part 34, of future issuances of securities and assumptions of 
liability, is August 30, 2017.
    The Commission encourages electronic submission of protests and 
interventions in lieu of paper, using the FERC Online links at http://www.ferc.gov. To facilitate electronic service, persons with Internet 
access who will eFile a document and/or be listed as a contact for an 
intervenor must create and validate an eRegistration account using the 
eRegistration link. Select the eFiling link to log on and submit the 
intervention or protests.
    Persons unable to file electronically should submit an original and 
5 copies of the intervention or protest to the Federal Energy 
Regulatory Commission, 888 First Street NE., Washington, DC 20426.
    The filings in the above-referenced proceeding are accessible in 
the Commission's eLibrary system by clicking on the appropriate link in 
the above list. They are also available for electronic review in the 
Commission's Public Reference Room in Washington, DC. There is an 
eSubscription link on the Web site that enables subscribers to receive 
email notification when a document is added to a subscribed docket(s). 
For assistance with any FERC Online service, please email 
<a href="/cdn-cgi/l/email-protection#d1979483929ebfbdb8bfb482a4a1a1bea3a591b7b4a3b2ffb6bea7"><span class="__cf_email__" data-cfemail="05434057464a6b696c6b60567075756a777145636077662b626a73">[email protected]</span></a>. or call (866) 208-3676 (toll free). For 
TTY, call (202) 502-8659.

    Dated: August 10, 2017.
Kimberly D. Bose,
Secretary.
[FR Doc. 2017-17356 Filed 8-16-17; 8:45 am]
BILLING CODE 6717-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
<TABLE>
<CAPTION>

                                                                          Exhibit 11

                                                      COMMERCE GROUP CORP. AND CONSOLIDATED SUBSIDIARIES

                                                        SCHEDULE OF COMPUTATION OF NET INCOME PER SHARE

                                                                         Years Ended March 31
                                                                    2001               2000                 1999
                                                       --------     ----   --------    ----   -----------   ----

BASIC

Net income (loss) for primary income per common
<S>                                                        <C>                 <C>                  <C>
share                                                      $     129,790       $  (396,232)         $   (90,266)
                                                           =============       ============         ============

Weighted average number of common shares
outstanding during the year - basic                           14,174,662         12,172,867           11,165,127
                                                       ==     ==========   ==    ==========   ==      ==========

Income (loss) per common share - basic                   $         .0092     $      (.0326)       $      (.0081)
                                                         ===============     ==============       ==============

DILUTED

Net income (loss) for basic and diluted income per
common share                                               $     129,790       $  (396,232)        $    (90,266)
                                                           =============       ============        =============

Weighted average number of common shares used in
calculating income per
common share                                                  14,174,662         12,172,867           11,165,127

Add incremental shares representing:
  Shares issuable upon exercise of stock
  options                                                        920,000          1,254,900              977,400

Shares issuable upon payment of stock loans and
interest                                                               0                  0               45,606

Stock rights                                                           0            625,235              625,235
                                                       -----------------   -----    -------   -----      -------

Weighted average number of shares used in
calculation of fully diluted income per share
                                                              15,094,662         14,053,002           12,813,368
                                                              ==========         ==========           ==========

Fully diluted income (loss) per common
share                                                      $       .0086       $    (.0282)        $     (.0070)
                                                           =============       ============        =============
</TABLE>